These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34286504)

  • 1. Association between serum amyloid A levels and predicting disase severity in COVID-19 patients: a systematic review and meta-analysis.
    Zhang D; Huang WJ; Lan MQ; Gan FR; Liu YY; Sun L; Chen JL; Sun YF; Tao CM
    Eur Rev Med Pharmacol Sci; 2021 Jul; 25(13):4627-4638. PubMed ID: 34286504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum amyloid A concentrations, COVID-19 severity and mortality: An updated systematic review and meta-analysis.
    Zinellu A; Paliogiannis P; Carru C; Mangoni AA
    Int J Infect Dis; 2021 Apr; 105():668-674. PubMed ID: 33737133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between serum amyloid A levels and coronary heart disease: a systematic review and meta-analysis of 26 studies.
    Zhou J; Lu Y; Wang S; Chen K
    Inflamm Res; 2020 Apr; 69(4):331-345. PubMed ID: 32088731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between serum amyloid A levels and cancers: a systematic review and meta-analysis.
    Zhou J; Sheng J; Fan Y; Zhu X; Tao Q; He Y; Wang S
    Postgrad Med J; 2018 Sep; 94(1115):499-507. PubMed ID: 30341230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-γ-induced protein 10 (IP-10) and serum amyloid A (SAA) are excellent biomarkers for the prediction of COVID-19 progression and severity.
    Haroun RA; Osman WH; Eessa AM
    Life Sci; 2021 Mar; 269():119019. PubMed ID: 33454365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of serum amyloid A in COVID-19: A meta-analysis.
    Li Y; Xiaojing H; Zhuanyun L; Li D; Yang J
    Medicine (Baltimore); 2022 Feb; 101(7):e28880. PubMed ID: 35363202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expressions of SAA, CRP, and FERR in different severities of COVID-19.
    Liu SL; Wang SY; Sun YF; Jia QY; Yang CL; Cai PJ; Li JY; Wang L; Chen Y
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11386-11394. PubMed ID: 33215460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Amyloid A Levels and Severity of COVID-19 in Children.
    Tasar S; Karadag-Oncel E; Elvan-Tuz A; Sahin A; Ustundag G; Ekemen-Keles Y; Onur S; Isbilen-Basok B; Kara-Aksay A; Yilmaz-Ciftdogan D
    Indian Pediatr; 2023 Mar; 60(3):217-220. PubMed ID: 36916361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Complement C3 and C4 and COVID-19 Severity and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression.
    Zinellu A; Mangoni AA
    Front Immunol; 2021; 12():696085. PubMed ID: 34163491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of coronavirus disease 2019 (COVID-19) in patients out of Wuhan from China: a case control study.
    Zhang H; Du F; Cao XJ; Feng XL; Zhang HP; Wu ZX; Wang BF; Zhang HJ; Liu R; Yang JJ; Ning B; Chen K; Huang ZP
    BMC Infect Dis; 2021 Feb; 21(1):207. PubMed ID: 33627079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Amyloid A in Inflammatory Rheumatic Diseases: A Compendious Review of a Renowned Biomarker.
    Sorić Hosman I; Kos I; Lamot L
    Front Immunol; 2020; 11():631299. PubMed ID: 33679725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between Serum Amyloid A Levels and Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.
    Liu T; Li M; Cui C; Zhou J
    Endocrinol Metab (Seoul); 2023 Jun; 38(3):315-327. PubMed ID: 37280788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting Disease Severity and Outcome in COVID-19 Patients: A Review of Multiple Biomarkers.
    Tjendra Y; Al Mana AF; Espejo AP; Akgun Y; Millan NC; Gomez-Fernandez C; Cray C
    Arch Pathol Lab Med; 2020 Dec; 144(12):1465-1474. PubMed ID: 32818235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of serum amyloid A for predicting the severity and recovery of COVID-19.
    Fu J; Huang PP; Zhang S; Yao QD; Han R; Liu HF; Yang Y; Zhang DY
    Exp Ther Med; 2020 Oct; 20(4):3571-3577. PubMed ID: 32855710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Type I Interferon Levels and COVID-19 Severity: A Systematic Review and Meta-Analysis.
    da Silva RP; Gonçalves JIB; Zanin RF; Schuch FB; de Souza APD
    Front Immunol; 2021; 12():657363. PubMed ID: 34054820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of serum amyloid A and prognosis in people with diabetes and COVID-19: A retrospective cohort study.
    Qu D; Liu J; Zhou L; Yang Y; Wu C; Xu X; Zhu Q; Wang C; Zhao X
    J Diabetes Investig; 2024 Jan; 15(1):44-51. PubMed ID: 38031656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of acute-phase reaction proteins to the diagnosis and treatment of 2019 novel coronavirus disease (COVID-19).
    Li L; Chen C
    Epidemiol Infect; 2020 Jul; 148():e164. PubMed ID: 32713370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dynamics of inflammatory markers in coronavirus disease-2019 (COVID-19) patients: A systematic review and meta-analysis.
    Mahat RK; Panda S; Rathore V; Swain S; Yadav L; Sah SP
    Clin Epidemiol Glob Health; 2021; 11():100727. PubMed ID: 33778183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum cortisol concentration and COVID-19 severity: a systematic review and meta-analysis.
    Amiri-Dashatan N; Koushki M; Parsamanesh N; Chiti H
    J Investig Med; 2022 Mar; 70(3):766-772. PubMed ID: 35058334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of laboratory parameters in mild
    Cao B; Jing X; Liu Y; Wen R; Wang C
    J Thorac Dis; 2022 May; 14(5):1478-1487. PubMed ID: 35693606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.